Aigen Investment Management’s Twist Bioscience TWST Stock Holding History

Aigen Investment Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,212	Closed	-$428K	–	989
2025 Q3	$428K	Buy	+15,212	New	+$461K	0.07%	436
2025 Q1	–	Sell	-6,376	Closed	-$296K	–	1041
2024 Q4	$296K	Sell	6,376 -2,661	-29%	-$120K	0.05%	482
2024 Q3	$408K	Buy	9,037 +4,125	+84%	+$196K	0.08%	378
2024 Q2	$242K	Sell	4,912 -5,591	-53%	-$228K	0.05%	562
2024 Q1	$360K	Buy	10,503 +3,895	+59%	+$141K	0.08%	374
2023 Q4	$244K	Buy	+6,608	New	+$153K	0.04%	580
2022 Q1	–	Sell	-2,910	Closed	-$243K	–	1089
2021 Q4	$243K	Buy	+2,910	New	+$299K	0.01%	866
2021 Q2	–	Sell	-24,068	Closed	-$2.98M	–	738
2021 Q1	$2.98M	Buy	+24,068	New	+$3.65M	0.39%	65

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Aigen Investment Management's TWST Position: Q4 2025 in Review

Aigen Investment Management sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 15,212 shares — an estimated $428K sold.

Aigen Investment Management first reported a position in TWST in Q1 2021 and held it in 8 quarters. The position peaked at $2.98M in Q1 2021. 243 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

Aigen Investment Management reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
Aigen Investment Management sold 15,212 Twist Bioscience shares in Q4 2025, an estimated $428K.
Aigen Investment Management first reported a position in Twist Bioscience in Q1 2021 and held it in 8 quarters.
Aigen Investment Management's Twist Bioscience position peaked at $2.98M in Q1 2021.
243 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.